Schierhout G, Roberts I
Department of Epidemiology and Public Health, University College London Medical School.
BMJ. 1998 Mar 28;316(7136):961-4. doi: 10.1136/bmj.316.7136.961.
To determine the effect on mortality of rescuscitation with colloid solutions compared with resuscitation with crystalloids.
Systematic review of randomised controlled trials of resuscitation with colloids compared with crystalloids for volume replacement of critically ill patients; analysis stratified according to patient type and quality of allocation concealment.
37 randomised controlled trials were eligible, of which 26 unconfounded trials compared colloids with crystalloids (n = 1622). (The 10 trials that compared colloid in hypertonic crystalloid with isotonic crystalloid (n = 1422) and one trial that compared colloid in isotonic crystalloid with hypertonic crystalloid (n = 38) are described in the longer version on our website www.bmj.com).
Mortality from all causes at end of follow up for each trial.
Resuscitation with colloids was associated with an increased absolute risk of mortality of 4% (95% confidence interval 0% to 8%), or four extra deaths for every 100 patients resuscitated. The summary effect measure shifted towards increased mortality with colloids when only trials with adequate concealment of allocation were included. There was no evidence for differences in effect among patients with different types of injury that required fluid resuscitation.
This systematic review does not support the continued use of colloids for volume replacement in critically ill patients.
确定与晶体液复苏相比,胶体液复苏对死亡率的影响。
对危重症患者容量替代时胶体液与晶体液复苏的随机对照试验进行系统评价;根据患者类型和分配隐藏质量进行分层分析。
37项随机对照试验符合条件,其中26项无混杂因素的试验比较了胶体液与晶体液(n = 1622)。(10项比较高渗晶体液中的胶体液与等渗晶体液的试验(n = 1422)以及1项比较等渗晶体液中的胶体液与高渗晶体液的试验(n = 38)在我们的网站www.bmj.com上的较长版本中有描述)。
每项试验随访结束时的全因死亡率。
胶体液复苏与死亡率的绝对风险增加4%相关(95%置信区间0%至8%),即每100例接受复苏的患者中有4例额外死亡。当仅纳入分配隐藏充分的试验时,汇总效应量显示胶体液复苏使死亡率增加。对于需要液体复苏的不同类型损伤患者,未发现效应存在差异的证据。
本系统评价不支持继续将胶体液用于危重症患者的容量替代。